Overview
Status
Active
Registry date
2023-01-25
Share capital
5,000.00 PLN
Registered address
ul. Aleksandra Kamińskiego 6A/28, 03-130 Warszawa, Poland
Electronic delivery address
AE:PL-94195-20860-ATFFJ-23
Financials
Revenue history (in m)
Filing timeliness
2 of 3 financial statements were filed late (the longest delay 339 days for 2024). 1 of 3 audited by a statutory auditor.
- 202503/09/2026
- 202419/06/2026
- 202308/07/2024
Filed on timeDelayFiling deadline
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2025.
Results vs industry
Revenue
This companyUSD 8.43mMedianUSD 1.06mAverageUSD 22.41m
Net profit
This companyUSD 5.70kMedianUSD 37.20kAverageUSD 879.46k
Operating costs
This companyUSD 8.42mMedianUSD 921.66kAverageUSD 21.08m
Assets
This companyUSD 616.92kMedianUSD 609.79kAverageUSD 11.85m
Industry
Authorized Representatives
Andrej Levshik – Management Board Member
Siarhei Rabchanka – President of the Management Board
Manner of representation
Each member of the management board is authorized to make declarations on behalf of the company independently.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Andrej Levshikage 38 | 30 | $405.19 | 30% |
Siarhei Rabchankaage 40 | 70 | $945.43 | 70% |
Beneficial owners
| Person | Rights |
|---|---|
Bank accounts
Registered as a VAT taxpayer on 2023-02-01.
11 1090 1665 0000 0001 5304 3803
64 1090 1665 0000 0001 5304 4110
71 1090 1665 0000 0001 5363 9079
Debt
No entries in the National Debtors Register (KRZ).
Public aid
No public aid cases recorded in the last 10 years.
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Orkla CareS.A. | $43,777,691.06 | orklacare.com.pl | ||
| Centrum Zaopatrzenia Medycznego Cezal - WrocławS.A. | $25,656,815.87 | cezal.com.pl | ||
| Cirrosp. z o.o. | $25,051,212.29 | cirro.pl | ||
| Synkmedsp. z o.o. | $20,634,200.47 | synkmed.pl | ||
| EMS - Euromed Medical Solutionsp. z o.o. | $21,990,292.06 | euromed.net.pl | ||
| Intimexsp. z o.o. + limited partnership | $18,994,512.90 | intimex.com.pl | ||
| Ivoclar-Vivadent Polskasp. z o.o. | $17,154,419.26 | ivoclar.com | ||
| AO East Europesp. z o.o. | $13,998,610.57 | aoeasteurope.pl | ||
| Medif sp. z o.o.sp. k. | $13,126,958.83 | medif.com | ||
| PromedS.A. | $12,643,674.56 | promed.com.pl |
Change history
| Date | Event | |
|---|---|---|
| 2024-06-18 | Address change (Ul. Grunwaldzka 10/1, 31-526, Kraków → Ul. Aleksandra Kamińskiego 6a/28, 03-130, Warszawa) | |
| 2024-04-25 | PKD change (Removed: 46.6; Added: 46, 73) | |
| 2023-03-01 | Address change (Ul. Hoża 86/410, 00-682, Warszawa → Ul. Grunwaldzka 10/1, 31-526, Kraków) | |
| 2023-03-01 | PKD change (Removed: 46; Added: 46.6) | |
| 2023-01-25 | Entered in the register |
FAQ
The main business activity of Nachtega focuses on wholesale of pharmaceutical goods.
The company was registered in the Polish National Court Register (KRS) on January 25, 2023.
The headquarters is located at: ul. Aleksandra Kamińskiego 6A, 03-130 Warszawa.
The share capital of the company is PLN 5,000 (approx. $1,351).
The latest available financial statement covers the period from January 1, 2025 to December 31, 2025.
The company reported a revenue of USD 8,431,013 in 2025, which is a decrease of 66.6% compared to 2024.
Yes, in 2025 the company was profitable, achieving a net profit of USD 5,702, meaning the company decreased its profit by 98.4%.
The largest operating cost category falls under cost of goods and materials sold. This category amounted to USD 8,176,094 in 2025, representing 97% of all operating expenses.
Last updated: 2026-09-10